scholarly journals Connecting the Mind–Body Split: Understanding the Relationship between Symptoms and Emotional Well-Being in Chronic Pain and Functional Gastrointestinal Disorders

Healthcare ◽  
2017 ◽  
Vol 5 (4) ◽  
pp. 93 ◽  
Author(s):  
Line Caes ◽  
Alex Orchard ◽  
Deborah Christie
Author(s):  
Adam Snider ◽  
Omid Naim

This chapter reviews the clinical utility of various mind–body interventions (MBIs) in the treatment of functional gastrointestinal disorders (FGID), including cognitive behavioral therapy, mindfulness, yoga, hypnosis, and biofeedback. Chronic or traumatic stress may dysregulate functions of the autonomic nervous system and lead to maladaptive changes in the brain–gut axis. Optimized regulation of the autonomic nervous system improves gastrointestinal function and may be a common factor in various MBIs used to treat stress-related FGID. In recent years, an expansion of randomized controlled trials and meta-analyses has provided additional evidence supporting the use of MBIs in treatment of FGID symptoms and related quality of life. This chapter includes a theoretical discussion of the stress response, the relaxation response, and the role of the mind as a regulatory process. The chapter also addresses practical issues relevant to incorporating MBIs into the treatment of FGID, including the doctor–patient relationship and successful referral to an MBI practice or provider.


CNS Spectrums ◽  
2005 ◽  
Vol 10 (11) ◽  
pp. 891-896 ◽  
Author(s):  
Kevin W. Olden

ABSTRACTSince their introduction 50 years ago, antidepressants have been used in a wide variety of settings involving gastrointestinal (GI) disease. In the 1950s, antidepressants were shown to have some efficacy for the treatment of peptic ulcer disease. This is most likely due to their antihistaminic and anticholinergic effects. Since then, more efficacious and more disease-specific treatments have become available. In the last 20 years, antidepressants have been increasingly used for the treatment of functional gastrointestinal disorders such as irritable bowel syndrome, noncardiac chest pain, and other functional GI disorders. This article will review the rationale for the use of antidepressant drugs for the treatment of functional GI disorders. The role of psychiatric comorbidity in functional GI disorders, the impact of antidepressants on GI motility and visceral sensation, and the ability of these agents to produce improvements in the global well-being and overall quality of life will be reviewed. Finally, guidelines for prescribing and barriers to a patient's acceptance of these agents will be discussed.


2020 ◽  
Vol 46 (10) ◽  
pp. 1411-1427 ◽  
Author(s):  
Michael L. Slepian ◽  
Katharine H. Greenaway ◽  
E. J. Masicampo

Having secrets on the mind is associated with lower well-being, and a common view of secrets is that people work to suppress and avoid them—but might people actually want to think about their secrets? Four studies examining more than 11,000 real-world secrets found that the answer depends on the importance of the secret: People generally seek to engage with thoughts of significant secrets and seek to suppress thoughts of trivial secrets. Inconsistent with an ironic process account, adopting the strategy to suppress thoughts of a secret was not related to a tendency to think about the secret. Instead, adopting the strategy to engage with thoughts of a secret was related the tendency to think about the secret. Moreover, the temporal focus of one’s thoughts moderated the relationship between mind-wandering to the secret and well-being, with a focus on the past exacerbating a harmful link. These results suggest that people do not universally seek to suppress their secrets; they also seek to engage with them, although not always effectively.


2019 ◽  
Vol 45 (1) ◽  
pp. 110-119
Author(s):  
Alexandra D Monzon ◽  
Christopher C Cushing ◽  
Craig A Friesen ◽  
Jennifer V Schurman

Abstract Objective Adolescents with chronic pain associated with functional gastrointestinal disorders (FGIDs) experience negative impacts on their health behaviors (i.e., sleep) and are at risk for a range of problems related to negative affect, which may serve to exacerbate one another in a reciprocal fashion. This study aimed to determine if the strength of the relationship between affect and sleep differs across community adolescents and adolescents with FGIDs. It was hypothesized that shorter sleep durations would be associated with more negative affect and longer sleep durations would be associated with more positive affect, and that group membership would moderate these relationships. Methods Twenty-five adolescents with FGIDs were compared with 25 matched peers to examine the differential association between affect and total sleep time (TST). Models were estimated using SAS PROC MIXED for inter- and intraindividual differences. Results Models predicting TST revealed a significant three-way interaction among weekday, group status, and negative affect. Simple slopes indicated that when negative affect is one standard deviation below the child’s own average on weekends, participants with FGIDs obtained significantly more sleep than those in the comparison group (β = 47.67, p < .05). Conclusions The findings of the present study show that when adolescents with FGIDs have lower negative affect on the weekend, when demands are likely reduced, they are able to obtain more TST. These findings confirm that unique relationships exist between negative affect and sleep duration for youth with FGIDs, and their interaction may hold value in understanding and addressing these targets.


Sign in / Sign up

Export Citation Format

Share Document